Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

Cette thérapie permet de transformer les cellules immunitaires en arme contre le cancer grâce à une injection chez la souris

Une avancée majeure en thérapie génique permet de reprogrammer les cellules immunitaires directement dans le corps pour cibler les tumeurs,

<![CDATA[Rationale and Timing: The Evolving Role of BCMA-Targeted Therapies in Relapsed/Refractory Multiple Myeloma ]]>

<![CDATA[Relapsed/Refractory Multiple Myeloma: Interpreting MonumenTAL-3 Efficacy and Safety Findings]]>

<![CDATA[BCMA Biology, Mechanisms of Action, and Unmet Needs in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[Relapsed/Refractory Multiple Myeloma: Rationale and Design of the MonumenTAL-3 Study]]>

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly a